ICAD Reports Growing Adoption Of Its Xoft Electronic Brachytherapy System By Leading U.S. Regional Hospitals

iCAD, Inc. (Nasdaq: ICAD), a leading provider of advanced imaging and radiation therapy for the early identification and treatment of cancer, today announced growing demand for and adoption of its Xoft® Axxent® Electronic Brachytherapy System® for intraoperative radiation therapy (“IORT”). Two new facilities have purchased the Xoft System including Florida Hospital Celebration Health (Celebration, Fla.) and Yuma Regional Medical Center (Yuma, Ariz.).

The Xoft System is FDA-cleared for the treatment of early stage breast cancer, endometrial cancer, skin cancer and for the treatment of other cancers or conditions where radiation therapy is indicated. As a platform technology, the Xoft System is designed to deliver isotope-free radiation therapy directly to cancer sites during surgery with minimal radiation exposure to surrounding healthy tissue.

“The continued adoption of the Xoft System emphasizes that it is increasingly being used nationwide, in large and small communities, at large and small hospitals and underscores the growing demand for IORT and other electronic brachytherapy treatments. In fact, Xoft System sales in the third quarter of this year equaled total sales in all of fiscal year 2011,” said Ken Ferry, President and CEO of iCAD. “Xoft provides radiation oncologists with an advanced, potentially life-saving radiation therapy option that can dramatically reduce treatment times, while providing more convenient and cosmetically desirable outcomes.”

Florida Hospital Celebration Health is using the Xoft System to deliver IORT for breast cancer. IORT delivers a single, prescribed, targeted dose of isotope-free radiation directly to the tumor cavity during surgery, thereby minimizing radiation to healthy tissue and organs and eliminating the need for a shielded treatment environment. Typical radiation therapy methods for breast cancer include whole breast radiation, which involves daily treatments for five to seven weeks, and partial breast irradiation where 10 treatments are delivered over a period of five days. Florida Hospital Celebration Health is also participating in the company’s 10 year post-market IORT study of the Xoft® Axxent® Electronic Brachytherapy System® for early stage breast cancer.

1 2 Next › Last »